Anti-annexin V antibodies in patients with cerebrovascular disease
Identifieur interne : 008064 ( Main/Exploration ); précédent : 008063; suivant : 008065Anti-annexin V antibodies in patients with cerebrovascular disease
Auteurs : N. Gašperši [Slovénie] ; U. Rot [Slovénie] ; S. U Nik [Slovénie] ; T. Kveder [Slovénie] ; B. Boži [Slovénie] ; B. Rozman [Slovénie]Source :
- Annals of the Rheumatic Diseases [ 0003-4967 ] ; 2003-02.
Descripteurs français
- Wicri :
- topic : Maladie cardio-vasculaire, Chiffre d'affaires.
English descriptors
- KwdEn :
- Aanxv, Abnormality, Aicher, American college, Ankylosing, Ankylosing spondylitis, Antinuclear antibodies, Antiphospholipid antibodies, Antiphospholipid syndrome, Apnoea syndrome, Arteritis, Arthritis, Arthritis rheum, Basdai, Baseline, Bath ankylosing spondylitis disease activity index, Bone density, Bone markers, Bone mineral density, Bone turnover, Bronchoalveolar lavage, Cardiovascular disease, Cell viability, Centre, Cervical spine disease, Chest expansion, Chest hrct, Chest radiographs, Clin, Clinical manifestations, Consecutive patients, Control group, Corticosteroid treatment, Daytime sleepiness, Depression scale, Diagnostic criteria, Disease activity, Dmard treatment, Dudley group, Encoding, Encoding mrna, Encoding transcripts, Eosinophilic fasciitis, Epworth sleepiness scale, Erythrocyte sedimentation rate, Fatigue component, Femoral neck, Fetal loss, Fibroblast, Fracture, Further studies, Giant cell arteritis, Healthy control subjects, Healthy controls, Helier hospital, Hospital anxiety, Hrct, Immunosorbent assay, Interstitial, Interstitial abnormalities, Interstitial lung disease, June, Kinase, Letters authors, Ligand, Longitudinal phase, Longitudinal study, Lumbar spine, Lupus, Lupus anticoagulant, Lymphocyte, Methotrexate, Mild right, Military hospital mohamed, Neck circumference, Negative control, Night oximetry, Okadaic acid, Orthopaedic surgery, Other factors, Other hand, Overall basdai scores, Phorbol ester, Plain radiography, Polynuclear neutrophils, Positive control, Product sizes, Protein kinase, Protein kinase inhibitor staurosporine, Psoriatic arthritis, Pulmonary function testing, Reactive protein, Respiratory symptoms, Rheum, Rheumatoid, Rheumatoid arthritis, Rheumatol, Rheumatology, Risk factors, Second passage, Serum levels, Serum samples, Skeletal sites, Sleepiness, Spinal involvement, Spondylitis, Staurosporine, Stress fracture, Syndrome, Synovial, Synovial fibroblasts, Systemic, Systemic disease, Systemic lupus erythematosus, Temporal arteritis, Turbidimetric immunoassay, Turnover, Untreated cells, Variable effects, York criteria, Young patients, anti-annexin antibodies, cerebrovascular disease.
- Teeft :
- Aanxv, Abnormality, Aicher, American college, Ankylosing, Ankylosing spondylitis, Antinuclear antibodies, Antiphospholipid antibodies, Antiphospholipid syndrome, Apnoea syndrome, Arteritis, Arthritis, Arthritis rheum, Basdai, Baseline, Bath ankylosing spondylitis disease activity index, Bone density, Bone markers, Bone mineral density, Bone turnover, Bronchoalveolar lavage, Cardiovascular disease, Cell viability, Centre, Cervical spine disease, Chest expansion, Chest hrct, Chest radiographs, Clin, Clinical manifestations, Consecutive patients, Control group, Corticosteroid treatment, Daytime sleepiness, Depression scale, Diagnostic criteria, Disease activity, Dmard treatment, Dudley group, Encoding, Encoding mrna, Encoding transcripts, Eosinophilic fasciitis, Epworth sleepiness scale, Erythrocyte sedimentation rate, Fatigue component, Femoral neck, Fetal loss, Fibroblast, Fracture, Further studies, Giant cell arteritis, Healthy control subjects, Healthy controls, Helier hospital, Hospital anxiety, Hrct, Immunosorbent assay, Interstitial, Interstitial abnormalities, Interstitial lung disease, June, Kinase, Letters authors, Ligand, Longitudinal phase, Longitudinal study, Lumbar spine, Lupus, Lupus anticoagulant, Lymphocyte, Methotrexate, Mild right, Military hospital mohamed, Neck circumference, Negative control, Night oximetry, Okadaic acid, Orthopaedic surgery, Other factors, Other hand, Overall basdai scores, Phorbol ester, Plain radiography, Polynuclear neutrophils, Positive control, Product sizes, Protein kinase, Protein kinase inhibitor staurosporine, Psoriatic arthritis, Pulmonary function testing, Reactive protein, Respiratory symptoms, Rheum, Rheumatoid, Rheumatoid arthritis, Rheumatol, Rheumatology, Risk factors, Second passage, Serum levels, Serum samples, Skeletal sites, Sleepiness, Spinal involvement, Spondylitis, Staurosporine, Stress fracture, Syndrome, Synovial, Synovial fibroblasts, Systemic, Systemic disease, Systemic lupus erythematosus, Temporal arteritis, Turbidimetric immunoassay, Turnover, Untreated cells, Variable effects, York criteria, Young patients.
Url:
DOI: 10.1136/ard.62.2.188
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 006F60
- to stream Istex, to step Curation: 006F60
- to stream Istex, to step Checkpoint: 003690
- to stream Main, to step Merge: 008299
- to stream Main, to step Curation: 008064
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Anti-annexin V antibodies in patients with cerebrovascular disease</title>
<author><name sortKey="Gaspersi, N" sort="Gaspersi, N" uniqKey="Gaspersi N" first="N" last="Gašperši">N. Gašperši</name>
</author>
<author><name sortKey="Rot, U" sort="Rot, U" uniqKey="Rot U" first="U" last="Rot">U. Rot</name>
</author>
<author><name sortKey=" U Nik, S" sort=" U Nik, S" uniqKey=" U Nik S" first="S" last=" U Nik">S. U Nik</name>
</author>
<author><name sortKey="Kveder, T" sort="Kveder, T" uniqKey="Kveder T" first="T" last="Kveder">T. Kveder</name>
</author>
<author><name sortKey="Bozi, B" sort="Bozi, B" uniqKey="Bozi B" first="B" last="Boži">B. Boži</name>
</author>
<author><name sortKey="Rozman, B" sort="Rozman, B" uniqKey="Rozman B" first="B" last="Rozman">B. Rozman</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E0B51C21E16FC9007046B8B0F3E4A2CA9904BE1A</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1136/ard.62.2.188</idno>
<idno type="url">https://api.istex.fr/document/E0B51C21E16FC9007046B8B0F3E4A2CA9904BE1A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006F60</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006F60</idno>
<idno type="wicri:Area/Istex/Curation">006F60</idno>
<idno type="wicri:Area/Istex/Checkpoint">003690</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003690</idno>
<idno type="wicri:doubleKey">0003-4967:2003:Gaspersi N:anti:annexin:v</idno>
<idno type="wicri:Area/Main/Merge">008299</idno>
<idno type="wicri:Area/Main/Curation">008064</idno>
<idno type="wicri:Area/Main/Exploration">008064</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Anti-annexin V antibodies in patients with cerebrovascular disease</title>
<author><name sortKey="Gaspersi, N" sort="Gaspersi, N" uniqKey="Gaspersi N" first="N" last="Gašperši">N. Gašperši</name>
<affiliation wicri:level="1"><country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rot, U" sort="Rot, U" uniqKey="Rot U" first="U" last="Rot">U. Rot</name>
<affiliation wicri:level="1"><country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Neurology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey=" U Nik, S" sort=" U Nik, S" uniqKey=" U Nik S" first="S" last=" U Nik">S. U Nik</name>
<affiliation wicri:level="1"><country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kveder, T" sort="Kveder, T" uniqKey="Kveder T" first="T" last="Kveder">T. Kveder</name>
<affiliation wicri:level="1"><country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bozi, B" sort="Bozi, B" uniqKey="Bozi B" first="B" last="Boži">B. Boži</name>
<affiliation wicri:level="1"><country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rozman, B" sort="Rozman, B" uniqKey="Rozman B" first="B" last="Rozman">B. Rozman</name>
<affiliation wicri:level="1"><country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint><publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2003-02">2003-02</date>
<biblScope unit="volume">62</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="188">188</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aanxv</term>
<term>Abnormality</term>
<term>Aicher</term>
<term>American college</term>
<term>Ankylosing</term>
<term>Ankylosing spondylitis</term>
<term>Antinuclear antibodies</term>
<term>Antiphospholipid antibodies</term>
<term>Antiphospholipid syndrome</term>
<term>Apnoea syndrome</term>
<term>Arteritis</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Basdai</term>
<term>Baseline</term>
<term>Bath ankylosing spondylitis disease activity index</term>
<term>Bone density</term>
<term>Bone markers</term>
<term>Bone mineral density</term>
<term>Bone turnover</term>
<term>Bronchoalveolar lavage</term>
<term>Cardiovascular disease</term>
<term>Cell viability</term>
<term>Centre</term>
<term>Cervical spine disease</term>
<term>Chest expansion</term>
<term>Chest hrct</term>
<term>Chest radiographs</term>
<term>Clin</term>
<term>Clinical manifestations</term>
<term>Consecutive patients</term>
<term>Control group</term>
<term>Corticosteroid treatment</term>
<term>Daytime sleepiness</term>
<term>Depression scale</term>
<term>Diagnostic criteria</term>
<term>Disease activity</term>
<term>Dmard treatment</term>
<term>Dudley group</term>
<term>Encoding</term>
<term>Encoding mrna</term>
<term>Encoding transcripts</term>
<term>Eosinophilic fasciitis</term>
<term>Epworth sleepiness scale</term>
<term>Erythrocyte sedimentation rate</term>
<term>Fatigue component</term>
<term>Femoral neck</term>
<term>Fetal loss</term>
<term>Fibroblast</term>
<term>Fracture</term>
<term>Further studies</term>
<term>Giant cell arteritis</term>
<term>Healthy control subjects</term>
<term>Healthy controls</term>
<term>Helier hospital</term>
<term>Hospital anxiety</term>
<term>Hrct</term>
<term>Immunosorbent assay</term>
<term>Interstitial</term>
<term>Interstitial abnormalities</term>
<term>Interstitial lung disease</term>
<term>June</term>
<term>Kinase</term>
<term>Letters authors</term>
<term>Ligand</term>
<term>Longitudinal phase</term>
<term>Longitudinal study</term>
<term>Lumbar spine</term>
<term>Lupus</term>
<term>Lupus anticoagulant</term>
<term>Lymphocyte</term>
<term>Methotrexate</term>
<term>Mild right</term>
<term>Military hospital mohamed</term>
<term>Neck circumference</term>
<term>Negative control</term>
<term>Night oximetry</term>
<term>Okadaic acid</term>
<term>Orthopaedic surgery</term>
<term>Other factors</term>
<term>Other hand</term>
<term>Overall basdai scores</term>
<term>Phorbol ester</term>
<term>Plain radiography</term>
<term>Polynuclear neutrophils</term>
<term>Positive control</term>
<term>Product sizes</term>
<term>Protein kinase</term>
<term>Protein kinase inhibitor staurosporine</term>
<term>Psoriatic arthritis</term>
<term>Pulmonary function testing</term>
<term>Reactive protein</term>
<term>Respiratory symptoms</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatol</term>
<term>Rheumatology</term>
<term>Risk factors</term>
<term>Second passage</term>
<term>Serum levels</term>
<term>Serum samples</term>
<term>Skeletal sites</term>
<term>Sleepiness</term>
<term>Spinal involvement</term>
<term>Spondylitis</term>
<term>Staurosporine</term>
<term>Stress fracture</term>
<term>Syndrome</term>
<term>Synovial</term>
<term>Synovial fibroblasts</term>
<term>Systemic</term>
<term>Systemic disease</term>
<term>Systemic lupus erythematosus</term>
<term>Temporal arteritis</term>
<term>Turbidimetric immunoassay</term>
<term>Turnover</term>
<term>Untreated cells</term>
<term>Variable effects</term>
<term>York criteria</term>
<term>Young patients</term>
<term>anti-annexin antibodies</term>
<term>cerebrovascular disease</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Aanxv</term>
<term>Abnormality</term>
<term>Aicher</term>
<term>American college</term>
<term>Ankylosing</term>
<term>Ankylosing spondylitis</term>
<term>Antinuclear antibodies</term>
<term>Antiphospholipid antibodies</term>
<term>Antiphospholipid syndrome</term>
<term>Apnoea syndrome</term>
<term>Arteritis</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Basdai</term>
<term>Baseline</term>
<term>Bath ankylosing spondylitis disease activity index</term>
<term>Bone density</term>
<term>Bone markers</term>
<term>Bone mineral density</term>
<term>Bone turnover</term>
<term>Bronchoalveolar lavage</term>
<term>Cardiovascular disease</term>
<term>Cell viability</term>
<term>Centre</term>
<term>Cervical spine disease</term>
<term>Chest expansion</term>
<term>Chest hrct</term>
<term>Chest radiographs</term>
<term>Clin</term>
<term>Clinical manifestations</term>
<term>Consecutive patients</term>
<term>Control group</term>
<term>Corticosteroid treatment</term>
<term>Daytime sleepiness</term>
<term>Depression scale</term>
<term>Diagnostic criteria</term>
<term>Disease activity</term>
<term>Dmard treatment</term>
<term>Dudley group</term>
<term>Encoding</term>
<term>Encoding mrna</term>
<term>Encoding transcripts</term>
<term>Eosinophilic fasciitis</term>
<term>Epworth sleepiness scale</term>
<term>Erythrocyte sedimentation rate</term>
<term>Fatigue component</term>
<term>Femoral neck</term>
<term>Fetal loss</term>
<term>Fibroblast</term>
<term>Fracture</term>
<term>Further studies</term>
<term>Giant cell arteritis</term>
<term>Healthy control subjects</term>
<term>Healthy controls</term>
<term>Helier hospital</term>
<term>Hospital anxiety</term>
<term>Hrct</term>
<term>Immunosorbent assay</term>
<term>Interstitial</term>
<term>Interstitial abnormalities</term>
<term>Interstitial lung disease</term>
<term>June</term>
<term>Kinase</term>
<term>Letters authors</term>
<term>Ligand</term>
<term>Longitudinal phase</term>
<term>Longitudinal study</term>
<term>Lumbar spine</term>
<term>Lupus</term>
<term>Lupus anticoagulant</term>
<term>Lymphocyte</term>
<term>Methotrexate</term>
<term>Mild right</term>
<term>Military hospital mohamed</term>
<term>Neck circumference</term>
<term>Negative control</term>
<term>Night oximetry</term>
<term>Okadaic acid</term>
<term>Orthopaedic surgery</term>
<term>Other factors</term>
<term>Other hand</term>
<term>Overall basdai scores</term>
<term>Phorbol ester</term>
<term>Plain radiography</term>
<term>Polynuclear neutrophils</term>
<term>Positive control</term>
<term>Product sizes</term>
<term>Protein kinase</term>
<term>Protein kinase inhibitor staurosporine</term>
<term>Psoriatic arthritis</term>
<term>Pulmonary function testing</term>
<term>Reactive protein</term>
<term>Respiratory symptoms</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatol</term>
<term>Rheumatology</term>
<term>Risk factors</term>
<term>Second passage</term>
<term>Serum levels</term>
<term>Serum samples</term>
<term>Skeletal sites</term>
<term>Sleepiness</term>
<term>Spinal involvement</term>
<term>Spondylitis</term>
<term>Staurosporine</term>
<term>Stress fracture</term>
<term>Syndrome</term>
<term>Synovial</term>
<term>Synovial fibroblasts</term>
<term>Systemic</term>
<term>Systemic disease</term>
<term>Systemic lupus erythematosus</term>
<term>Temporal arteritis</term>
<term>Turbidimetric immunoassay</term>
<term>Turnover</term>
<term>Untreated cells</term>
<term>Variable effects</term>
<term>York criteria</term>
<term>Young patients</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Maladie cardio-vasculaire</term>
<term>Chiffre d'affaires</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Slovénie</li>
</country>
</list>
<tree><country name="Slovénie"><noRegion><name sortKey="Gaspersi, N" sort="Gaspersi, N" uniqKey="Gaspersi N" first="N" last="Gašperši">N. Gašperši</name>
</noRegion>
<name sortKey=" U Nik, S" sort=" U Nik, S" uniqKey=" U Nik S" first="S" last=" U Nik">S. U Nik</name>
<name sortKey="Bozi, B" sort="Bozi, B" uniqKey="Bozi B" first="B" last="Boži">B. Boži</name>
<name sortKey="Kveder, T" sort="Kveder, T" uniqKey="Kveder T" first="T" last="Kveder">T. Kveder</name>
<name sortKey="Rot, U" sort="Rot, U" uniqKey="Rot U" first="U" last="Rot">U. Rot</name>
<name sortKey="Rozman, B" sort="Rozman, B" uniqKey="Rozman B" first="B" last="Rozman">B. Rozman</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008064 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008064 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:E0B51C21E16FC9007046B8B0F3E4A2CA9904BE1A |texte= Anti-annexin V antibodies in patients with cerebrovascular disease }}
![]() | This area was generated with Dilib version V0.6.32. | ![]() |